Formulation and evaluation of polymeric nanoparticles of an antihypetensive drug labetalol
Abstract
Labetalol is an adrenergic receptor blocking agent used in the treatment of hypertension and characterized by high solubility and high permeability which corresponds to BCS class I drug. Plasma half life ranges from 6 & bioavailability is 25%. Ethyl cellulose was used as a rate controlling polymer. Effects of addition of ethyl cellulose on in vitro dissolution were studied. Nanoparticles were formulated using different polymer ratios. In vitro drug release was carried out by using USP Type II at 50 rpm in 900 ml of acidic dissolution medium (pH 1.2) for 2 hours, followed by 900 ml alkaline dissolution medium (pH7.4) for 12 hours. Mean dissolution time is used to characterize drug release rate from a dosage form. Several kinetic models were applied to the dissolution profiles to determine the drug release kinetics. Excipients are selected by FTIR studies. Finally the nanoparticles were evaluated for various characteristics like encapsulation efficiency, percentage yield, partial size and the In vitro release for 12 hrs. The nanoparticles were found to be discrete, spherical, and free-flowing. The nanoparticles were uniform in size, and the microencapsulation efficiency was in the range of 52.5-81.7%. The surface morphology of prepared Labetalol nanoparticles was observed under scanning electron Microscopy. Nanoparticles had good spherical geometry. The stability study was performed at 40ºC ± 2ºC and 75 ± 5% RH for 6 months.
Keywords: Nanoparticles; Labetalol, Hypertension, Ethyl Cellulose, Dissolution, entrapment efficiency.
DOI
https://doi.org/10.22270/jddt.v8i6-s.2109References
Peltonen L., Koistinen P., Karjalainen M.,Hakkinen A., Hirvonen J., The effect ofcosolvents on the formulation of nanoparticles from low molecular weight poly(l)lactide, AAPS PharmSciTech, 2002; 3:1-7.
Cui F., Oian F., Yin C., Preparation and characterization of mucoadhesive polymercoated nanopaticles, Int. J. Pharm., 2006; 316:154-161.13.
Saparia B., Murthy R.S.R., Solanki A.,Preparation and evaluation of chloroquine phosphate microspheres using cross-linked gelatin for long term drug delivery, Indian J. Pharm. Sci., 2002; 64:48-52.
Haznedar S., Dortunc B., Preparation and evaluation of Eudragit microspheres containing acetazolamide, Int. J. Pharm.,2004; 269:131-140.15.
Higuchi T., Mechanism of sustained actionmedication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J.Pharm. Sci., 1963; 52:1145-1149.
Ramteke S., Maheshwari R.B.V., Jain N. K., Clarithromycin based oral sustained release nanoparticulate drug delivery system, Indian J. Pharm. Sci., 2006; 68:479-484.
Shashikanth D. Barhate, Yogesh S. Rupnar, Rupesh M. Sonvane et al. Formulation and evaluation of floating nanoparticles of ketorolac trometamol, IJPRD. 2009; 1(9):1-8
Atul D karande, Pramod G. Yeole. Comparative assessment of different dissolution apparatus for floating drug delivery systems. Dissolution technologies. 2006: 20-26
Ram C. Dhakar, Maurya SD, Saluja V. From formulation variables to drug entrapment efficiency of nanoparticles: A technical review. Journal of Drug Delivery and Therapeutics, 2012; 2(6):128-133. https://doi.org/10.22270/jddt.v2i6.160
Sachin B Somwanshi, Ramdas T Dolas, Vikrant K Nikam., Floating multiparticulate oral sustained release drug delivery system. J. Chem. Pharm. Res., 2011; 3(1):536-547.
Ramesh C Nagarwal, Devendra N Ridhurkar, J K Pandit. In-vitro release kinetics and bioavailability of gastroretentivecinnarizineHCl tablet. AAPS PharmaSci Tech. 2010; 11(1):294-303.
Barratt G. Characterization of colloidal drug carrier systems with zeta potential measurements. Pharma Tech Eur 1999; 11:25–32.
Deshpande AA, Rhodes TN and Shah H. Controlled release drug delivery systems for prolonged gastric residence an overview. Drug dev Ind pharm 1996; 22:531-539.
Garg R and Gupta GD (2008). Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 7: 1055-1066.
Gupta SN and Aggarwal N. A gastro-retentive floating delivery system for 5-Fluorouracil. Asian Journal of Pharmaceutical Sciences 2007; 2:143-149.
Hejazi R and Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003; 89:151-165.
Hwang SJ, Park H and Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug 1998; 15: 243-248.
Lueben HL, Lehr CM, Rentel CO, Noach ABJ, Boer AGD, Verhoef JC and Junginger HE. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release 1994; 29: 329-338
M, Indumathy R, Sreeram KJ and Balachandran U. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull Mater Sci 2008; 31:93-96.
Park K and Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm 1984; 19:107-127.
Patel JK and Patel MM. Stomach Specific Anti-Helicobacter Pylori Therapy: Preparation and Evaluation of Amoxicillin – Loaded Chitosan Muco adhesive Nanoparticles. Curr Drug Deliv 2007; 4:41-50.
Pignatello R, Ricupero N, Bucolo, Maugeri F, Maltese A and Puglisi G. Preparation and characterization of eudragit retard nanasuspensions for the ocular delivery of cloricromene. AAPS Pharm SciTech 2006; 24(7):E27.
Published
Abstract Display: 1226 
PDF Downloads: 1288 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.